Emmaus Medical Inc.

Description

Mr. Ludlum is the Chief Financial Officer at Emmaus Medical, Inc. He has over 30 years of experience in accounting and finance. His prior healthcare industry experience includes having served as the Financial Compliance Officer and as the Chief Financial Officer of Applied Medical Resources Corporation, Group Controller for IsoTis S.A., Chief Financial Officer of GenSci Regeneration Sciences Inc. and Chief Financial Officer of Pacific Biometrics, Inc.

Emmaus Medical, a wholly-owned subsidiary of Emmaus Life Sciences, is engaged in the discovery, development, and commercialization of innovative and cost-effective treatments and therapies for rare diseases. Currently, the primary focus of our business is the late-stage development -- presently in Phase III clinical trials with the FDA – of the amino acid L-glutamine as a prescription drug for the treatment of Sickle Cell Disease.

Fact sheet

Products & services

Similar companies nearby